Free Trial

Pro-Dex (PDEX) Competitors

Pro-Dex logo
$44.40 -0.17 (-0.38%)
Closing price 04:00 PM Eastern
Extended Trading
$44.64 +0.25 (+0.55%)
As of 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PDEX vs. KIDS, NPCE, AXGN, SMLR, TMCI, CLPT, NNOX, STIM, SMTI, and SNWV

Should you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include OrthoPediatrics (KIDS), NeuroPace (NPCE), AxoGen (AXGN), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), and SANUWAVE Health (SNWV). These companies are all part of the "medical equipment" industry.

Pro-Dex vs.

OrthoPediatrics (NASDAQ:KIDS) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, profitability, risk and institutional ownership.

OrthoPediatrics currently has a consensus target price of $35.83, suggesting a potential upside of 64.00%. Pro-Dex has a consensus target price of $52.00, suggesting a potential upside of 17.12%. Given OrthoPediatrics' higher possible upside, equities analysts clearly believe OrthoPediatrics is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Pro-Dex has a net margin of 11.06% compared to OrthoPediatrics' net margin of -15.00%. Pro-Dex's return on equity of 21.68% beat OrthoPediatrics' return on equity.

Company Net Margins Return on Equity Return on Assets
OrthoPediatrics-15.00% -5.78% -4.80%
Pro-Dex 11.06%21.68%12.40%

Pro-Dex has lower revenue, but higher earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OrthoPediatrics$212.45M2.50-$20.97M-$1.75-12.49
Pro-Dex$64.12M2.26$2.13M$2.8015.86

OrthoPediatrics has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500.

OrthoPediatrics received 161 more outperform votes than Pro-Dex when rated by MarketBeat users. Likewise, 64.56% of users gave OrthoPediatrics an outperform vote while only 61.90% of users gave Pro-Dex an outperform vote.

CompanyUnderperformOutperform
OrthoPediatricsOutperform Votes
317
64.56%
Underperform Votes
174
35.44%
Pro-DexOutperform Votes
156
61.90%
Underperform Votes
96
38.10%

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by company insiders. Comparatively, 47.5% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, OrthoPediatrics had 3 more articles in the media than Pro-Dex. MarketBeat recorded 5 mentions for OrthoPediatrics and 2 mentions for Pro-Dex. OrthoPediatrics' average media sentiment score of 1.32 beat Pro-Dex's score of 1.26 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OrthoPediatrics
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Pro-Dex
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

OrthoPediatrics beats Pro-Dex on 10 of the 18 factors compared between the two stocks.

Get Pro-Dex News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDEX vs. The Competition

MetricPro-DexSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$144.79M$4.49B$5.37B$8.38B
Dividend YieldN/A43.63%5.22%4.11%
P/E Ratio22.0929.4326.8419.71
Price / Sales2.2667.72392.34117.39
Price / Cash34.8151.0838.2534.62
Price / Book4.556.236.794.50
Net Income$2.13M$68.16M$3.23B$248.18M
7 Day Performance2.45%18.33%4.07%1.14%
1 Month Performance-23.86%23.04%12.52%15.20%
1 Year Performance131.81%20.61%16.83%6.56%

Pro-Dex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDEX
Pro-Dex
2.5906 of 5 stars
$44.40
-0.4%
$52.00
+17.1%
+130.9%$144.79M$64.12M22.09140News Coverage
Positive News
Gap Up
KIDS
OrthoPediatrics
4.5945 of 5 stars
$22.95
-0.5%
$35.83
+56.1%
-29.6%$557.39M$212.45M-18.66200Positive News
NPCE
NeuroPace
1.4532 of 5 stars
$17.00
-2.8%
$15.00
-11.8%
+125.4%$556.80M$79.91M-17.00170High Trading Volume
AXGN
AxoGen
3.3869 of 5 stars
$11.76
-0.6%
$22.20
+88.8%
+86.6%$535.60M$194.52M-36.75450
SMLR
Semler Scientific
2.5481 of 5 stars
$43.27
+5.8%
$71.00
+64.1%
+78.4%$482.55M$56.29M8.81120Options Volume
Gap Up
High Trading Volume
TMCI
Treace Medical Concepts
2.286 of 5 stars
$6.73
+0.1%
$10.16
+50.9%
+35.4%$423.25M$210.82M-6.80250Trending News
Gap Up
CLPT
ClearPoint Neuro
1.7237 of 5 stars
$13.12
-0.5%
$25.00
+90.5%
+108.6%$368.90M$31.39M-19.01110Positive News
Gap Up
NNOX
Nano-X Imaging
1.4304 of 5 stars
$5.48
-2.1%
$12.00
+119.0%
-43.7%$316.63M$11.28M-6.45190News Coverage
Upcoming Earnings
Gap Up
STIM
Neuronetics
1.7482 of 5 stars
$4.29
+1.7%
$5.50
+28.2%
+69.6%$282.37M$89.45M-3.49180
SMTI
Sanara MedTech
1.7872 of 5 stars
$31.18
-1.0%
$49.50
+58.8%
-4.6%$277.13M$86.67M-31.4960Earnings Report
Analyst Revision
SNWV
SANUWAVE Health
N/A$29.58
-8.4%
N/AN/A$253.09M$36.19M-6.4940

Related Companies and Tools


This page (NASDAQ:PDEX) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners